ScoreWhy is Apyx Medical Corp. ?
1
Poor long term growth as Operating profit has grown by an annual rate 8.36% of over the last 5 years
2
Positive results in Jun 25
- PRE-TAX PROFIT(Q) Highest at USD -3.69 MM
- NET PROFIT(Q) Highest at USD -3.78 MM
- RAW MATERIAL COST(Y) Fallen by -54.79% (YoY)
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 177.78%, its profits have fallen by -1.6%
4
High Institutional Holdings at 58.19%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating performance in long term as well as near term
- Along with generating 177.78% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Apyx Medical Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Apyx Medical Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Apyx Medical Corp.
144.24%
1.38
108.79%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.99%
EBIT Growth (5y)
8.36%
EBIT to Interest (avg)
-12.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
1.02
Tax Ratio
1.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
58.19%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.00
EV to EBIT
-4.36
EV to EBITDA
-4.53
EV to Capital Employed
4.76
EV to Sales
1.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-109.14%
ROE (Latest)
-191.62%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
PRE-TAX PROFIT(Q)
Highest at USD -3.69 MM
NET PROFIT(Q)
Highest at USD -3.78 MM
RAW MATERIAL COST(Y)
Fallen by -54.79% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 3.88 times
OPERATING PROFIT(Q)
Highest at USD -2.44 MM
EPS(Q)
Highest at USD -0.09
-3What is not working for the Company
ROCE(HY)
Lowest at -156.9%
DEBT-EQUITY RATIO
(HY)
Highest at 134.8 %
Here's what is working for Apyx Medical Corp.
Pre-Tax Profit
Highest at USD -3.69 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -3.78 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Profit
Highest at USD -2.44 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
EPS
Highest at USD -0.09
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 3.88 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -54.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Apyx Medical Corp.
Debt-Equity Ratio
Highest at 134.8 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
